Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-04Clinical Trial Update: PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment [Phase 1]
Phase 1 trial of PU-H71 in patients with solid tumors and low-grade non-Hodgkin's lymphoma that failed standard therapy; study terminated wi…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial of ME-344 combined with Hycamtin (topotecan) in solid tumors was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Dose-Escalation and Safety Trial of YN968D1 [Phase 1, Phase 2]
Phase 1/2 dose-escalation and safety trial update for YN968D1 in cancer patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial [Phase 3]
A Phase 3 treatment extension study for patients who previously participated and benefited from iniparib; completed trial.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer [Phase 1]
Phase 1 study evaluating the AKT inhibitor MK-2206 in combination with Paclitaxel for locally advanced or metastatic solid tumors and metast…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors [Phase 1]
This update reports the completion of a Phase 1, first‑in‑human study of escalating oral doses of TVB-2640 in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma [Phase 1]
Phase I open-label dose-escalation trial of the investigational compound GSK1059615 in patients with solid tumors or lymphoma was terminated…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors [Phase 1, Phase 2]
Early-phase clinical trial evaluating haploidentical transplant with NK cell infusion for pediatric leukemia and solid tumors; study termina…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors [Phase 1]
Phase 1 bioavailability study of GSK1363089 in subjects with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: CDDO to Treat Solid Tumors and Lymphomas [Phase 1]
The National Cancer Institute-sponsored Phase 1 trial evaluated CDDO in patients with solid tumors and lymphoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Simultaneous Care: Linking Palliation to Clinical Trials [NA]
This is a completed clinical trial update from the University of California, Davis about linking palliation to participation in clinical tri…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012) [Phase 1]
Phase 1 study of pembrolizumab (MK-3475) in advanced solid tumors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors [Phase 1]
Completed Phase 1 dose-escalation trial evaluating the combination of gemcitabine and ON-01910.Na in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer [Phase 1]
A Phase 1 trial evaluating the safety of ON 01910.Na given as a 3-day infusion in patients with advanced cancer has completed; the document …
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating the safety of EF-022, a Modified Vitamin D Binding Protein Macrophage Activator, in subjects with advanc…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies. [Phase 1]
Phase 1 study assessing how radiolabeled E7080 (lenvatinib) is metabolized and eliminated in patients with advanced solid tumors or lymphoma…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors [Phase 1]
This document reports results from a Phase 1 bioequivalence study comparing two oral formulations of Topotecan in patients with advanced sol…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of RAD001 (everolimus) and AMG479 (ramucirumab) in patients with advanced solid tumors. The trial h…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies [Phase 1, Phase 2]
Phase 1b/2 safety and tolerability study of MEDI6469 with therapeutic immune agents or monoclonal antibodies in patients with advanced solid…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors [Phase 1]
Phase 1 study evaluating gefitinib (ZD1839) in combination with irinotecan and vincristine in pediatric patients with refractory solid tumor…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Safety Study of Infusion of SGT-53 to Treat Solid Tumors [Phase 1]
Completion of a Phase 1 safety study evaluating infusion of SGT-53 for treating solid tumors, sponsored by SynerGene Therapeutics.
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating Urelumab (BMS-663513) in patients with advanced/metastatic solid tumors and relapsed/refractory B-cell non-Hodgkin'…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 open-label trial evaluating ruxolitinib in combination with chemotherapy for advanced solid tumors, terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309 [Phase 1]
Phase 1 study assessing safety, pharmacokinetics, and pharmacodynamics of PQR309 in patients with advanced solid tumors; the trial has compl…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of GDC-0425 with and without gemcitabine in patients with refractory…